← All organizations

Levitection Ltd.

Israeli advanced-radar and electronic-warfare company - the SECOND Barak-brokered defence investment, and the source of figures long misattributed to Carbyne

Companies he did business withPerson affiliated

Also written: Levitection, Levitection Ltd, CWEW-Q Levitection

The second Israeli defence-technology investment Ehud Barak brought to Jeffrey Epstein, and the reason a false claim about Carbyne survived on this site for months. In April 2016 Barak pitched it (EFTA00326339): "Dr. Levite presented the science to me in much more details. Couldn't see a product, they don't have it yet. But they're leading experts on advanced radars. Made sci-fi like achievements in military products." He proposed explicitly to reuse the Carbyne structure: "I propose we have a similar arrangement to the one we had in Reporty", and "I will send Udi to negotiate better financial terms with them. Based on the same construct we used in Reporty. You or Darren, and me will be updated along the way. Then, based on what he can get we will make the final decision. Do you agree?" Jeffrey Epstein replied: "interested, both pages exhibit little financial experience. have you seen a demonstration?" Two term sheets followed, in May/June and on 7 July 2016 (EFTA00588982, EFTA00599472). Both name the founders as Dr. Gideon Levita and Mr. Raviv Levita, and both name the investor as "An entity under the control of Mr. Ehud Barak" - Jeffrey Epstein does not appear on the face of the documents at all, while Barak is emailing him for the decision. That is the same concealment shape as Carbyne, where Barak told Jeffrey Epstein and Nicole Junkermann that the founder-CEO and a sitting director "are not fully aware of your partnership with me".

THIS COMPANY'S NUMBERS ARE THE ONES PEOPLE MISQUOTE AS CARBYNE'S. The $1,020,000 initial plus $680,000 deferred tranches, the $2.19 price per share, the $2,715,584 pre-money valuation, the 27.3% then 38.5% shareholding and the move of a liquidation-preference termination threshold from 2x to 3.5x are ALL Levitection. They appear in Darren Indyke's 3 August 2016 memo EFTA00822267, which is headed "Re: Levitection" and sets them out under "Quick summary of Levitection based on current docs". The same memo gives Carbyne's separate and different terms: "the Reporty deal was a $1.5MM investment total for not less than 25% of a Company with a pre-money valuation of $4.5MM", liquidation preference "based on an interest rate of 8% per year, compounded annually". A published finding of ours conflated the two and asserted that Jeffrey Epstein held "a 38.5% controlling stake" in Carbyne; corrected 4 August 2026. Second caution: both Levitection documents are term SHEETS and say so - "not intended to be a legally binding agreement but is a statement of intent". Indyke's August memo shows the deal reached share-purchase-agreement drafting, but no document in the corpus establishes that it closed, and the 38.5% is a projected post-tranche shareholding rather than a recorded holding.

BusinessAdvanced radar and military electronic-warfare research; Barak's own note says they had no product yet
FoundersDr. Gideon Levita and Mr. Raviv Levita (both term sheets)
Investor of record"An entity under the control of Mr. Ehud Barak" - Jeffrey Epstein is not named in either term sheet
Proposed structureUS$1,020,000 initial plus US$680,000 deferred, at US$2.19 per share, pre-money valuation US$2,715,584
Projected shareholding27.3% after the initial tranche, 38.5% after the deferred tranche - PROJECTED, not recorded as held
Term sheet datesMay/June 2016 (EFTA00588982) and 7 July 2016 (EFTA00599472)
Pitched18 April 2016 by Ehud Barak, proposing "a similar arrangement to the one we had in Reporty" (EFTA00326339)
Jeffrey Epstein's response"interested, both pages exhibit little financial experience. have you seen a demonstration?"

People #

Being named in these records is not by itself an allegation about anyone listed.

Related findings #

Source documents #

Cited above

EFTA00326339 EFTA00588982 EFTA00599472 EFTA00822267